| Assets | — | — |
| Non-current assets | — | — |
| Property, plant and equipment | 9.46a | 9.51a |
| Right-of-use assets | 1.42a | 1.41a |
| Goodwill | 24.76a | 23.34a |
| Intangible assets other than goodwill | 26.92a | 26.88a |
| Investments in associated companies | 0.12a | 0.21a |
| Deferred tax assets | 4.36a | 4.31a |
| Financial assets | 2.02a | 2.61a |
| Other non-current assets | 3.51a | 1.2a |
| Total non-current assets | 72.54a | 69.46a |
| Current assets | — | — |
| Inventories | 5.72a | 5.91a |
| Trade receivables | 7.42a | 7.11a |
| Income tax receivables | 0.13a | 0.43a |
| Marketable securities, commodities, time deposits and derivative financial instruments | 2a | 1.04a |
| Cash and cash equivalents | 11.46a | 13.39a |
| Other current assets | 2.97a | 2.61a |
| Total current assets | 29.7a | 30.48a |
| Total assets | 102.25a | 99.95a |
| Equity and liabilities | — | — |
| Equity | — | — |
| Share capital | 0.79a | 0.83a |
| Treasury shares | -0.05a | -0.04a |
| Reserves | 43.31a | 45.88a |
| Equity attributable to Novartis AG shareholders | 44.05a | 46.67a |
| Non-controlling interests | 0.08a | 0.08a |
| Total equity | 44.13a | 46.75a |
| Liabilities | — | — |
| Non-current liabilities | — | — |
| Financial debts | 21.37a | 18.44a |
| Lease liabilities | 1.57a | 1.6a |
| Deferred tax liabilities | 2.42a | 2.25a |
| Provisions and other non-current liabilities | 4.08a | 4.52a |
| Total non-current liabilities | 29.43a | 26.81a |
| Current liabilities | — | — |
| Trade payables | 4.57a | 4.93a |
| Financial debts and derivative financial instruments | 8.23a | 6.18a |
| Lease liabilities | 0.24a | 0.23a |
| Current income tax liabilities | 1.6a | 1.89a |
| Provisions and other current liabilities | 14.05a | 13.17a |
| Total current liabilities | 28.69a | 26.39a |
| Total liabilities | 58.12a | 53.2a |
| Total equity and liabilities | 102.25a | 99.95a |